new_0222_0451|ORIC|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0451|ORIC|1|ORIC Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|ORIC Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|ORIC Pharmaceuticals Inc Inventories (Quarterly) (USD)|ORIC Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|ORIC Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|ORIC Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|ORIC Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|ORIC Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|ORIC Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|ORIC Pharmaceuticals Inc Book Value (Quarterly) (USD)|ORIC Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|ORIC Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|ORIC Pharmaceuticals Inc EV to Revenues|ORIC Pharmaceuticals Inc EV to Earnings|ORIC Pharmaceuticals Inc EV to Free Cash Flow|ORIC Pharmaceuticals Inc EV to Assets (Quarterly)|ORIC Pharmaceuticals Inc PS Ratio|ORIC Pharmaceuticals Inc PE Ratio|ORIC Pharmaceuticals Inc Price to Book Value|ORIC Pharmaceuticals Inc PEG Ratio|ORIC Pharmaceuticals Inc Debt to Equity Ratio|ORIC Pharmaceuticals Inc Dividend Yield|ORIC Pharmaceuticals Inc Shareholder Yield (TTM)|ORIC Pharmaceuticals Inc Percent of Shares Outstanding Short|ORIC Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|ORIC Pharmaceuticals Inc Total Payables (Quarterly) (USD)|ORIC Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|ORIC Pharmaceuticals Inc Return on Invested Capital|ORIC Pharmaceuticals Inc Quality Ratio Score|ORIC Pharmaceuticals Inc Momentum Score|ORIC Pharmaceuticals Inc Beta (1Y)|ORIC Pharmaceuticals Inc Sustainable Growth Rate (TTM)|ORIC Pharmaceuticals Inc Institutional Investor Ownership Percentage|ORIC Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|ORIC Pharmaceuticals Inc Total Employees (Annual)|ORIC Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|ORIC Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|ORIC Pharmaceuticals Inc Shares Outstanding|ORIC Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|ORIC Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|ORIC Pharmaceuticals Inc Payout Ratio|ORIC Pharmaceuticals Inc Quick Ratio (Quarterly)|ORIC Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|ORIC Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|ORIC Pharmaceuticals Inc Effective Tax Rate (TTM)|ORIC Pharmaceuticals Inc Return on Equity|ORIC Pharmaceuticals Inc Net Income (TTM) (USD)|ORIC Pharmaceuticals Inc Revenue (TTM) (USD)|ORIC Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|ORIC Pharmaceuticals Inc Revenue (Quarterly) (USD)|ORIC Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|ORIC Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|ORIC Pharmaceuticals Inc Net Income (Quarterly) (USD)|ORIC Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|ORIC Pharmaceuticals Inc Price (USD)|ORIC Pharmaceuticals Inc Total Return Price (USD)|ORIC Pharmaceuticals Inc Enterprise Value (USD)|ORIC Pharmaceuticals Inc 30-Day Average Daily Volume|ORIC Pharmaceuticals Inc 1 Year Price Returns (Daily)|ORIC Pharmaceuticals Inc Short Interest|ORIC Pharmaceuticals Inc PE Ratio (Forward)|ORIC Pharmaceuticals Inc PE Ratio (Forward 1y)|ORIC Pharmaceuticals Inc PS Ratio (Forward)|ORIC Pharmaceuticals Inc PS Ratio (Forward 1y)|ORIC Pharmaceuticals Inc Quarterly EPS Estimates (USD)|ORIC Pharmaceuticals Inc Quarterly Revenue Estimates (USD)|ORIC Pharmaceuticals Inc Quarterly EPS Surprise|ORIC Pharmaceuticals Inc Quarterly Revenue Surprise|ORIC Pharmaceuticals Inc Quarterly Actual EPS (USD)|ORIC Pharmaceuticals Inc Quarterly Actual Revenue (USD)|ORIC Pharmaceuticals Inc Revenue Estimates for Current Fiscal Year (USD)|ORIC Pharmaceuticals Inc Revenue Estimates for Next Fiscal Year (USD)|ORIC Pharmaceuticals Inc Price Target (USD)|ORIC Pharmaceuticals Inc Consensus Recommendation|ORIC Pharmaceuticals Inc Price Target Num Estimates|ORIC Pharmaceuticals Inc EPS Estimates for Current Fiscal Year (USD)|ORIC Pharmaceuticals Inc EPS Estimates for Next Fiscal Year (USD)|ORIC Pharmaceuticals Inc Research and Development Expense (Quarterly) (USD)|ORIC Pharmaceuticals Inc Reconciled Depreciation (Quarterly) (USD)|ORIC Pharmaceuticals Inc Non-Operating Interest Expense (Quarterly) (USD)|ORIC Pharmaceuticals Inc Land and Improvements (Quarterly) (USD)|ORIC Pharmaceuticals Inc Buildings and Improvements (Quarterly) (USD)|ORIC Pharmaceuticals Inc Other Properties (Quarterly) (USD)|ORIC Pharmaceuticals Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0451|ORIC|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0451|ORIC|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0451|ORIC|5|91.2857142857|91.2857142857||91.2857142857||91.2857142857|91.2857142857|91.2857142857||91.2857142857|91.2857142857||||1.44565217391||||1.44444444444|||1.44565217391||15.2619047619||91.2857142857|91.2857142857|||30.7142857143|30.6666666667|||91.4|91.2857142857|91.4|91.4|28.1||91.2857142857|||91.4|91.4444444444|||91.2857142857|||||91.4|91.4|91.4|1.44565217391|1.44565217391|1.44565217391|1.44547563805|1.43269230769|15.2619047619|||||91.3636363636|91.3636363636|91.3333333333||91.3333333333|91.3333333333|21.275862069|23.76|20.5666666667|9.07352941176|20.5666666667|16.6756756757|16.5|91.4|91.4||||91.2857142857|91.2857142857||
new_0222_0451|ORIC|6|7|7||7||7|7|7||7|7||||460||||414|||460||42||7|7|||7|9|||10|7|10|10|20||7|||10|9|||7|||||10|10|10|460|460|460|431|208|42|||||11|11|6||6|6|29|25|30|68|30|37|36|10|10||||7|7||
new_0222_0451|ORIC|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0451|ORIC|201903||||||||||||||||||||||||||||||||||19.1412||-0.3142|1.134||||||-0.3142|||||||||-6.015|-6.015|0.261||||||||||||||||||||||||5.212|0.242|||||||
new_0222_0451|ORIC|201906||||||||||||||||||||||||||||||||||19.1412||-0.3116|1.315||||||-0.3116|||||||||-5.965|-5.965|0.317||||||||||||||||||||||||5.04|0.246|||||||
new_0222_0451|ORIC|201909||||||||||||||||||||||||||||||||||19.1412||-0.3421|1.465||||||-0.3421|||||||||-6.549|-6.549|0.476||||||||||||||||||||||||5.632|0.27|||||||
new_0222_0451|ORIC|201912|89.999|89.159||2.241||184.177|5.354|178.823||-90.084|-92.69|||||||||||||||0.152||||||||19.1412|57|-0.4364|1.811|||27.5424|||-0.4364||||-26.883|||||-8.354|-8.354|0.343||||||||||||||||||||||||6.96|0.27||||3.748|0.298||
new_0222_0451|ORIC|202003|80.23|79.442||2.096||183.473|4.78|178.693||-98.417|-101.562||||-26.4117|||||||||2.2463||0.77||||||||27.5424|57|-0.3221|1.925|29.9174||27.5424|||-0.3221||||-29.74|||||-8.872|-8.872|0.241|26.45|26.45|711.8732|||672043|||||-0.4624||9.8261||-0.417||||40.75|1.75|4|-1.764|-2.1244|7.254|0.25||||3.855|0.296|29.02|
new_0222_0451|ORIC|202006|199.228|196.642||1.978||6.278|5.778|0.5||195.247|-112.586||||-26.3423||||5.1696|||||8.3772||1.389|0.003|||||||21.6274|58|-0.51|3.4|29.9245||29.9245|||-0.51|-138|||-34.799|||||-11.024|-11.024|0.025|33.73|33.73|812.7114|227338.8||2506836|||||-0.396||-28.7749||-0.51||||42.2|1.6|5|-1.5939|-2.1417|7.723|0.246||||3.933|0.346|20.07|25.05
new_0222_0451|ORIC|202009|189.058|186.61||1.893||7.287|6.928|0.359||184.375|-138.134||||-16.5409||||4.1434|||||7.0671||1.598|0.003||||||99.29|30.3149|60|-0.84|3.8|30.5452||30.5452|||-0.4121||||-53.798|||||-25.548|-25.548|0.01|25.01|25.01|577.3255|86746.0667||2158669|||||-0.395||-112.6744||-0.84||||43.7143|1.2857|7|-2.2072|-2.2322|8.831|0.24||||4.088|0.346|21.5|33.91
new_0222_0451|ORIC|202012|296.697|293.6||1.981||9.221|9.002|0.219||289.776|-166.393||||-20.6326||||4.2839|||||7.4055||0.757|0.004|||||||36.6724|61|-0.84|4.297|36.6724||36.6724|||-0.5163|-133.308|||-73.703|||||-28.259|-28.259|0.03|33.85|33.85|947.7607|357371.3||2715763|||||-0.4105||-18.7419||-0.4874||||44.1429|1.2857|7|-2.4083|-2.1364|12.113|0.234||||4.396|0.36|29.32|32.4
new_0222_0451|ORIC|202103|280.101|278.141||1.969||7.885|7.676|0.209||276.075|-182.902||||-11.7718||||3.2561|||||12.9547||0.606|0.004||||2.813|||36.6797|66|-0.45|4.856|36.6908||36.6908|||-0.45||||-81.34|||||-16.509|-16.509|0.044|24.5|24.5|620.7836|281814.8333|-8.7713|4753190|||||-0.4746||5.1893||-0.45||||44.4286|1.5714|7|-2.2348|-2.7321|11.697|0.229||||4.612|0.361|24.13|22.85
new_0222_0451|ORIC|202106|264.952|261.068||1.828||9.904|9.904|||258.323|-203.911||||-6.5505||||2.5143|||||15.0114||0.838|0.004|||2|2.9433|||36.7018|70|-0.57|5.54|36.7156||36.7156|||-0.57||||-91.325|||||-21.009|-21.009|0.033|17.69|17.69|388.431|257128.0333|-47.5541|5511540|||||-0.4918||-15.8961||-0.57||||43.1429|1.5714|7|-2.0768|-2.6824|15.517|0.222||||4.52|0.352|16.65|22.09
new_0222_0451|ORIC|202109|292.849|289.519||1.825||22.644|11.903|10.741||291.536|-222.337||||-8.5893||||2.821|||||7.6523||0.419|0.004|||3|3.547|||39.0081|74|-0.47|5.557|39.3316||39.3316|||-0.47|-50|||-84.203|||||-18.426|-18.426|0.03|20.91|20.91|532.9048|215602.1333|-16.3934|3009759|||||-0.5829||19.3659||-0.47||||43.4286|1.2857|7|-2.2271|-2.8808|12.899|0.217||||4.641|0.352|14.64|13.84
new_0222_0451|ORIC|202112|||||||||||||||-4.6644||||1.9857|||||6.7399||||||2|-0.5106||||||||||||||||||||||||14.7|14.7|289.3949|177627.0667|-56.5731|2654289|||||-0.5468||||||||32.1429|1.2857|7|-2.0358|-2.6512||||||||9.89|8.32
new_0222_0451|ORIC|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.5497|||||||||||||||||||||
new_0222_0451|ORIC|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.5821|||||||||||||||||||||
new_0222_0451|ORIC|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.6152|||||||||||||||||||||
new_0222_0451|ORIC|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.735|||||||||||||||||||||